DocGo Operating Income from 2010 to 2026
| DCGO Stock | USD 0.79 0.02 2.47% |
Operating Income | First Reported 2020-03-31 | Previous Quarter -17.5 M | Current Value -42 M | Quarterly Volatility 12.7 M |
Check DocGo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DocGo's main balance sheet or income statement drivers, such as Tax Provision of 17.4 M, Depreciation And Amortization of 11 M or Interest Expense of 2.4 M, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 2.4 K or PTB Ratio of 1.48. DocGo financial statements analysis is a perfect complement when working with DocGo Valuation or Volatility modules.
DocGo | Operating Income | Build AI portfolio with DocGo Stock |
Evaluating DocGo's Operating Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into DocGo Inc's fundamental strength.
Latest DocGo's Operating Income Growth Pattern
Below is the plot of the Operating Income of DocGo Inc over the last few years. Operating Income is the amount of profit realized from DocGo Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of DocGo Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. DocGo's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocGo's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
DocGo Operating Income Regression Statistics
| Arithmetic Mean | (4,342,278) | |
| Coefficient Of Variation | (523.22) | |
| Mean Deviation | 20,543,526 | |
| Median | (20,762,734) | |
| Standard Deviation | 22,719,538 | |
| Sample Variance | 516.2T | |
| Range | 55.4M | |
| R-Value | 0.86 | |
| Mean Square Error | 139.5T | |
| R-Squared | 0.75 | |
| Slope | 3,887,410 | |
| Total Sum of Squares | 8258.8T |
DocGo Operating Income History
Other Fundumenentals of DocGo Inc
DocGo Operating Income component correlations
Click cells to compare fundamentals
About DocGo Financial Statements
DocGo investors utilize fundamental indicators, such as Operating Income, to predict how DocGo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | 33 M | 34.6 M | |
| Non Operating Income Net Other | -888.7 K | -933.2 K |
Pair Trading with DocGo
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.Moving together with DocGo Stock
| 0.72 | IL3 | Integra LifeSciences Earnings Call This Week | PairCorr |
| 0.75 | EW | Edwards Lifesciences Corp | PairCorr |
Moving against DocGo Stock
| 0.85 | EDAP | EDAP TMS SA | PairCorr |
| 0.77 | HYB | HOYA | PairCorr |
| 0.77 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.76 | VREX | Varex Imaging Corp | PairCorr |
| 0.63 | DXCM | DexCom Inc | PairCorr |
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of DocGo Correlation against competitors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Will Health Care Equipment & Supplies sector continue expanding? Could DocGo diversify its offerings? Factors like these will boost the valuation of DocGo. Projected growth potential of DocGo fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DocGo data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.09 | Earnings Share (0.53) | Revenue Per Share | Quarterly Revenue Growth (0.49) | Return On Assets |
Investors evaluate DocGo Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating DocGo's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause DocGo's market price to deviate significantly from intrinsic value.
It's important to distinguish between DocGo's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocGo should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocGo's market price signifies the transaction level at which participants voluntarily complete trades.